2025, Atherosclerosis and Stenosis - Cardiovascular Update

Abstract WP56: Dental Flossing associated with reduced White Matter Hyperintensity and Intracranial Atherosclerosis

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. Introduction:Prior studies have shown the association between oral infection, white matter hyperintensity (WMH), a marker of cerebral small vessel disease (CSVD), and asymptomatic intracranial atherosclerosis (ICAS). CSVD was assessed using the log of WMH volume.

Atherosclerosis

Atherosclerosis Stenosis Risk Factors Education

Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last

Stroke Journal

MARCH 23, 2025

Stroke, Volume 56, Issue 4 , Page e114-e118, April 1, 2025. Intracranial atherosclerotic stenosis is a leading cause of stroke with a significant risk of recurrent ischemic events despite aggressive medical management. However, 3 percutaneous angioplasty and stenting randomized trials showed negative or neutral results.

Angioplasty

Angioplasty Stenosis Coronary Artery Disease Stent

Abstract WP203: Ipsilateral Hemodynamic Failure of Extracranial Internal Carotid Artery is Associated with Severe Middle Cerebral Artery Atherosclerosis——a 4D Flow MRI Study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP203-AWP203, February 1, 2025. Introduction:The middle cerebral artery (MCA) is the most common site for inrtacranial atherosclerotic stenosis. Evidence has shown that carotid artery geometries are independently associated with ipsilateral MCA atherosclerosis. 21.35), p<0.001).Conclusions:Both

Atherosclerosis

Atherosclerosis Stenosis Risk Factors BMI

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.

Cardiovascular Disease

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack

Abstract TP293: Association Between Aortic Arch Type and Lateralization of Subclavian Artery Stenosis: An Observational Cohort Study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP293-ATP293, February 1, 2025. Background and Objectives:Left subclavian artery (LSA) is more prone to atherosclerosis than the right one. The study was designed to investigate whether aortic arch types (AAT) was associated with the lateralization of subclavian artery stenosis (SAS).Methods:In

Stenosis

Stenosis Aortic Atherosclerosis Risk Factors

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease

Cardiovascular Disease Aortic valve Biomarkers Innovation

Abstract TP288: Prevalence and Gender Differences in Carotid Atherosclerosis Among Adults: Evidence from a Cohort Study in China

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP288-ATP288, February 1, 2025. Carotid atherosclerosis (CAS) is a critical precursor to atherosclerotic cardiovascular disease and is closely associated with the development and progression of conditions such as stroke and poor prognosis.

Atherosclerosis

Atherosclerosis Plaque Stenosis Cardiovascular Disease

Abstract TP318: Comparison of Lipid-Lowering Therapies Regimens and LDL-C Profiles in Patients with Asymptomatic versus Acute Symptomatic Atherosclerotic Carotid Stenosis

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP318-ATP318, February 1, 2025. Introduction:Elevated Low-Density-Lipoprotein Cholesterol (LDL-C) blood levels are a risk factor for atherosclerosis. After adjusting for confounders, only LDL-C levels were associated with the acute symptomatic status of carotid stenosis.

Stenosis

Stenosis Atherosclerosis Cholesterol Ischemia

Abstract TP220: Per-segment Evaluation of Atherosclerostic Stenosis of Intracranial Internal Carotid Artery: A hospital-based cross-sectional study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP220-ATP220, February 1, 2025. Background:The uneven distribution of intracranial atherosclerotic stenosis (ICAS) along the internal carotid artery (ICA) had been described in early clinicopathological studies, yet related, large-scale data is lack despite the widespread utilization of angiography.

Stenosis

Stenosis Hospital Atherosclerosis Risk Factors

Abstract WP276: Association Between Vertebral Artery Hypoplasia and Atherosclerotic Stenosis of Subclavian Artery, Vertebral Artery and Basilar Artery: An Observational Cohort Study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP276-AWP276, February 1, 2025. We aimed to investigate the association between VAH and atherosclerotic stenosis of subclavian artery (SA), vertebral artery (VA) and basilar artery (BA) based on digital subtraction angiography (DSA).Methods:In VAH and stenosis degree of the artery (i.e.,

Stenosis

Stenosis Atherosclerosis Risk Factors Strokes

Abstract WP190: Predicting Intracranial Atherosclerosis-related Large Vessel Occlusion Using Deep Learning on Neuroimaging and Clinical Data.

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP190-AWP190, February 1, 2025. Patients presenting intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) may benefit from performing an early bailout strategy after failed MT with conventional devices. cardioembolic).

Atherosclerosis

Atherosclerosis Strokes Stroke Stenosis

Abstract TP222: Impaired Distal Perfusion as a Predictor of Stroke Recurrence in Intracranial Atherosclerosis: A Single-Center Study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP222-ATP222, February 1, 2025. on univariate analyses (Wilcoxon rank-sum test and chi-square test) were identified as important outcome predictors.Results:We identified 114 patients hospitalized with symptomatic intracranial stenosis who met the inclusion criteria. Variables with p<0.05

Atherosclerosis

Atherosclerosis Strokes Stroke Stenosis

Abstract WMP107: Carotid Artery Assessment via Blood Acoustic Signatures Captured by a Wearable Seismometer Patch

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP107-AWMP107, February 1, 2025. Background:Early detection of carotid artery (CA) conditions such as atherosclerosis and dissection are important as they represent major preventable causes of stroke. These patients had varying CA conditions (atherosclerosis, dissection, normal, etc.)

Stenosis

Stenosis Atherosclerosis Ultrasound Strokes

Abstract 41: Territorial Stroke in SAMMPRIS: Critical Analyses of Stroke Prevention in Intracranial Atherosclerosis

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. This is largely due to the Stenting and Aggressive Medical Management Therapy for Preventing Recurrent Stroke in Intracranial Arterial Stenosis (SAMMPRIS) trial results which featured a high periprocedural stroke rate.

Strokes

Strokes Stroke Stent Stents

Abstract TMP98: Low-dose Rivaroxaban plus Antiplatelet Treatment in Patients With Symptomatic Intracranial Atherosclerotic Stenosis：A Prospective Observational Study

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP98-ATMP98, February 1, 2025. Background:The secondary prevention of symptomatic intracranial atherosclerotic stenosis (sICAS) remains a significant challenge.

Atherosclerosis

Atherosclerosis Strokes Stroke Stenosis

Abstract TMP54: Development and testing of a fully automated tool for the detection, segmentation, and characterization of cervical carotid atherosclerotic disease

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP54-ATMP54, February 1, 2025. Background:Rapid, accurate diagnosis and characterization of carotid atherosclerosis can help prevent disabling strokes. Although carotid plaques can be identified on CT angiography (CTA), interpretation is challenging for frontline physicians.

Plaque

Plaque Atherosclerosis Stenosis Strokes

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.

Cardiovascular Disease

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME

CME Obesity Heart Failure Biomarkers

Abstract WP56: Dental Flossing associated with reduced White Matter Hyperintensity and Intracranial Atherosclerosis

Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last

Abstract WP203: Ipsilateral Hemodynamic Failure of Extracranial Internal Carotid Artery is Associated with Severe Middle Cerebral Artery Atherosclerosis——a 4D Flow MRI Study

Webinars

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

Abstract TP293: Association Between Aortic Arch Type and Lateralization of Subclavian Artery Stenosis: An Observational Cohort Study

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

Abstract TP288: Prevalence and Gender Differences in Carotid Atherosclerosis Among Adults: Evidence from a Cohort Study in China

Abstract TP318: Comparison of Lipid-Lowering Therapies Regimens and LDL-C Profiles in Patients with Asymptomatic versus Acute Symptomatic Atherosclerotic Carotid Stenosis

Abstract TP220: Per-segment Evaluation of Atherosclerostic Stenosis of Intracranial Internal Carotid Artery: A hospital-based cross-sectional study

Abstract WP276: Association Between Vertebral Artery Hypoplasia and Atherosclerotic Stenosis of Subclavian Artery, Vertebral Artery and Basilar Artery: An Observational Cohort Study

Abstract WP190: Predicting Intracranial Atherosclerosis-related Large Vessel Occlusion Using Deep Learning on Neuroimaging and Clinical Data.

Abstract TP222: Impaired Distal Perfusion as a Predictor of Stroke Recurrence in Intracranial Atherosclerosis: A Single-Center Study

Abstract WMP107: Carotid Artery Assessment via Blood Acoustic Signatures Captured by a Wearable Seismometer Patch

Abstract 41: Territorial Stroke in SAMMPRIS: Critical Analyses of Stroke Prevention in Intracranial Atherosclerosis

Abstract TMP98: Low-dose Rivaroxaban plus Antiplatelet Treatment in Patients With Symptomatic Intracranial Atherosclerotic Stenosis：A Prospective Observational Study

Abstract TMP54: Development and testing of a fully automated tool for the detection, segmentation, and characterization of cervical carotid atherosclerotic disease

Trial Results: Low-Dose Colchicine Helps Treat Cardiovascular Disease

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC)

Stay Connected